共 50 条
- [44] Purinergic system dysfunction in mood disorders: a key target for developing improved therapeutics [J]. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2015, 57 : 117 - 131
- [46] MATCHING ANTIDEPRESSANT ACTION TO THE PATHOPHYSIOLOGY OF MOOD DISORDERS: A SCIENCE-BASED APPROACH TO TREATMENT DISCOVERY [J]. AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2018, 52 : 5 - 6
- [47] Microbiome abnormalities as a possible link between diabetes mellitus and mood disorders: Pathophysiology and implications for treatment [J]. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 2022, 137
- [49] Clinical studies implementing glutamate neurotransmission in mood disorders [J]. GLUTAMATE AND DISORDERS OF COGNITION AND MOTIVATION, 2003, 1003 : 292 - 308
- [50] Inflammation, Glutamate, and Glia: A Trio of Trouble in Mood Disorders [J]. Neuropsychopharmacology, 2017, 42 : 193 - 215